4 Interestingly, the AACE/ACE algorithm additionally makes non-insulin recommendations for patients who are optimized on basal insulin and require additional postprandial glycemic control
Someone splitting their weekly dose into twice-weekly injections, for example, can use a plotter to see how that changes their peak and trough pattern compared to a single weekly shot
One of the most striking is the pronounced circadian variation in symptom severity
Its been struggling, for sure, but this might be the tailwind it needs to make it attractive again, especially with up to 6 million lapsed members that have expressed willingness to pay to lose weight and who could be brough back in by marketing campaigns like this below (combined with the general social media reflexivity noted above with GLP-1 drugs): Dating Sites & Apps Its perhaps uncomfortable to confront but with nearly a third of every single person in the U.S
If large swathes of the general public start taking them off-label for weight loss and then we find out years later that there are bad side effects, it could be a real issue. Rethinking long-term weight management strategies to overcome cost barriers Yet another dimension affecting the use of GLP-1RAs is cost